
    
      This is a non-commercial, investigator-driven clinical study funded through a public
      competitive call by Instituto de Salud Carlos III, Spanish Ministry of Economy (PI17/01272).

      The study is coordinated by the main investigator from Hospital Universitario 12 de Octubre
      in Madrid; the sponsorship is performed by Dr. Adolfo Fontenla (Hospital Universitario 12 de
      Octubre). Several responsibilities are delegated to the Clinical Research Unit (Hospital 12
      de Octubre, Madrid, Spain).

      The study was planned according to the Good Clinical Practices. BRAKE-AF Study has been
      approved by the Ethics Committee and Spanish Health Authorities. All participating patients
      must give written informed consent before any study procedure occur.
    
  